EVGN · ISSUER CIK 1574565
Evogene Ltd.
Between Aug 1, 2026 and Oct 29, 2026, 2 Evogene Ltd. insiders reported $693K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Recanati Leon (Director), with $692K.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$693KInsider buying
$0.00Insider selling
+$693KNet open-market
Aug 26, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 202616:00 | Jun 4, 2026 | EVGN | Chief Development Officer | P · BuyLate 83d | $0.60 | +1,129 | 1,129 | New | +$677.40 | -35.5% | -36.7% |
| Aug 13, 202607:00 | Aug 11, 2026 | EVGN | Director | P · Buy | $0.64 | +460,000 | 1,343,886 | +52% | +$292K | -16.4% | -40.2% |
| Aug 5, 202616:07 | Aug 4, 2026 | EVGN | Director | P · Buy | $0.50 | +800,000 | 883,886 | +954% | +$400K | -36.7% | -24.0% |